Application of Ropivacaine Combined with Sufentanil Epidural Anesthesia in Pain Relief during Vaginal Delivery in Primiparas
Objective To explore the application effect of ropivacaine combined with sufentanil epidural anesthesia(EA)in pain relief during vaginal delivery(VD)in primiparas.Methods A total of 80 primiparas who underwent VD in Yongmei Group General Hospital from July 2019 to June 2023 were selected,and they were divided into the control group(40 cases)and the research group(40 cases)by the random number table method.Both groups were given EA,the control group used ropivacaine,and the research group used ropivacaine combined with sufentanil.The anesthesia indicators,pain degree,labor process,delivery outcome,and maternal and infant outcomes of the two groups were compared.Results The onset time and complete block time of the research group were shorter than those of the control group,and the duration of anesthesia was longer,with statistically significant differences(P<0.05).The Numeric Rating Scale(NRS)scores of the two groups 10 min,1 h,and 2 h after anesthesia were lower than before anesthesia,and the NRS scores of the research group at the same time were lower than those of the control group,with statistically significant differences(P<0.05).The first,second,and third stages of labor in the research group were shorter than those in the control group,with statistically significant differences(P<0.05).The rate of conversion to cesarean section in the research group(2.50%)was lower than that in the control group,with statistically significant differences(P<0.05).The rate of adverse maternal and infant outcomes in the research group(5.00%)was lower than that in the control group(22.50%),with statistically significant differences(P<0.05).Conclusion The application of ropivacaine combined with sufentanil EA in VD primiparas can improve anesthesia indicators,reduce the pain degree of primiparas,shorten the labor process,reduce the rate of conversion to cesarean section,and the occurrence rate of adverse maternal and infant outcomes.